Congestive Heart Failure & Angina

Welcome Nessage

Dear Esteemed Participants,

On behalf of the organizing committee, it is our great honor to welcome you to the 6^th World Congress on Congestive Heart Failure & Angina, scheduled for April 29-30, 2026, in Paris, France.

This year’s congress gathers leading cardiologists, researchers, clinicians, industry innovators, and healthcare professionals from across the globe to share knowledge, present the latest scientific advancements, and collaborate on strategies to transform the prevention, diagnosis, and management of heart failure and angina. With cardiovascular diseases continuing to be the leading cause of mortality worldwide, this congress serves as a vital platform to address emerging therapies, technological breakthroughs, and patient-centered care.

Whether you are joining as a speaker, presenter, or delegate, we encourage you to engage actively, exchange perspectives, and foster new collaborations. Together, let us advance the science and practice of cardiovascular medicine and shape a healthier future.

We look forward to welcoming you to Paris for an enriching and unforgettable experience of learning, networking, and innovation.

Warm regards,
Organizing Committee

About Conference

The 6^th World Congress on Congestive Heart Failure & Angina will be held on April 29-30, 2026, in Paris, France, bringing together global leaders, clinicians, scientists, researchers, and healthcare professionals to address the most pressing challenges in cardiovascular medicine. This premier event provides a dynamic forum for exchanging ideas, presenting cutting-edge research, and exploring the evolving landscape of cardiology.

The 2026 edition will spotlight a wide range of themes including pathophysiology of heart failure, advanced diagnostic tools, pharmacological and non-pharmacological therapies, interventional cardiology, regenerative medicine, and digital health innovations. With a comprehensive program of keynote lectures, symposia, oral and poster presentations, workshops, and panel discussions, the congress fosters collaboration between academia, industry, and clinical practice.

Whether you are a researcher driving new discoveries, a clinician enhancing patient outcomes, or an industry leader developing the next generation of cardiovascular solutions, this congress is your gateway to innovation and impact in the fight against heart failure and angina.

CONFERENCE AGENDA

Registration & Kit Collection: Delegates will begin with registration, receiving ID badges, conference kits, and the full agenda. On-site staff will be available to assist with any queries. Early arrival is encouraged.

Inaugural Session & Opening Remarks: The congress opens with a welcome note from the organizing committee, followed by keynote addresses from distinguished cardiology experts. A group photograph will conclude the session.

Scientific Sessions & Presentations: Parallel tracks will cover specialized topics, from biomarkers and imaging in heart failure to surgical interventions and lifestyle medicine. Oral, poster, and e-poster presentations will provide opportunities for participants to showcase their work.

Networking Breaks & Poster Walks: Tea/coffee breaks and poster sessions will allow attendees to interact, share feedback, and connect with peers and exhibitors.

Conference Lunch & Awards Ceremony: Delegates will enjoy networking luncheons. On the final day, awards for best oral and poster presentations will be presented, along with certificates and closing remarks.

Optional Activities: Delegates may join guided city tours or special networking dinners to explore Paris and build professional relationships.

Why To Attend?

Attending this conference offers a blend of knowledge, networking, and opportunity:

• Gain deep insights into the latest congestive heart failure and angina strategies and innovations.
• Engage with leading cardiologists, heart failure specialists, interventional cardiology experts, clinical researchers, and key healthcare decision-makers shaping cardiovascular care across Europe and beyond.
• Strengthen professional networks to support collaborations, research partnerships, and institutional linkages.
• Present your work to an international audience and enhance your academic and professional visibility.
• Access sessions focused on cutting-edge topics such as advanced cardiac imaging, heart failure phenotyping, ischemia and angina diagnostics, cardiology-based therapeutics, biomarker-driven risk stratification, cardiovascular device innovations, and emerging clinical management pathways.
• Participate in workshops that translate evidence into practice, offering tools that can be implemented in real-world settings.

Experience the cultural richness of Paris while being part of one of Europe’s most impactful health conferences.

Participation / Presentation Options

To ensure accessibility for global researchers and clinical professionals, the Summit offers multiple participation formats designed to support scientific exchange, visibility, and collaboration.

Oral Presentation: Showcase comprehensive studies, clinical trial outcomes, and novel cardiovascular biomarkers, advanced cardiac imaging techniques, heart-failure–focused diagnostics, or innovative therapeutic methodologies. Oral presenters will engage in interactive Q&A sessions with leading experts in cardiology, heart failure management, and ischemic heart disease research.

Poster Presentation: Ideal for early-stage studies, pilot data, method development, and exploratory work. Presenters engage with delegates during dedicated poster viewing and networking segments.

Virtual Presentation: A flexible option for participants unable to travel. Present your work online and receive equal recognition, certificates, and publication benefits as onsite presenters.

Delegate Participation: For professionals who wish to attend without presenting. Delegates gain full access to all scientific sessions, keynote talks, workshops, and networking activities.

Exhibitor & Sponsorship Opportunities: Designed for biotech firms, diagnostic companies, CROs, universities, and healthcare technology providers. Exhibitors can showcase products, services, and innovations to a global audience.

PARTICIPATION BENEFITS

Knowledge Enhancement & Skill Development:

• Learn from global leaders in cardiology, heart failure and ischemic heart disease management, precision therapeutics, advanced cardiovascular diagnostics, and translational cardiovascular research.
• Gain insights from keynote lectures, scientific sessions, expert panels, and hands-on workshops.
• Explore breakthroughs in multi-omics–based cardiac profiling, non-invasive cardiac assessment technologies, AI-enhanced cardiovascular diagnostics, and data-driven approaches transforming clinical cardiology and heart failure care.

Global Networking Opportunities:

• Meet researchers, clinicians, industry experts, and innovators from over 40 countries.
• Build partnerships for joint projects, publications, grants, and institutional collaborations.
• Connect with peers, mentors, and future employers in both academic and industrial settings.

Presentation & Publication Advantages:

Present your research through Oral, Poster, or Virtual formats.

Receive:

• Certificate of Presentation
• Certificate of Participation
• Official conference recognition

Selected abstracts will be included in conference proceedings or associated publications.

Early submissions receive priority scheduling and enhanced visibility.

Career Growth & Professional Development:

• Strengthen your academic profile and CV with participation in a globally recognized summit.
• Gain insights into emerging clinical research trends in cardiology, cardiovascular biomarker development and validation workflows, and evolving regulatory pathways shaping innovations in heart failure and angina diagnostics and therapeutics.
• Attend sessions on scientific leadership, research communication, and healthcare innovation.

Diverse Session Formats:

• Keynote sessions
• Scientific oral presentations
• Poster exhibitions
• Panel debates
• Specialized technical workshops
• Industry demonstrations

Each session is designed to encourage interactive learning and cross-disciplinary collaboration.

Resources & Post-Conference Access:

• Access recorded sessions (virtual and select categories).
• Download speaker presentations, session summaries, and conference materials.
• Continue networking through post-event communication channels.

Visa Assistance & Flexible Participation:

• Receive official invitation letters for visa processing.
• If travel is not possible, participants may switch to virtual mode or transfer registration as per policy.
• Hybrid options ensure participation regardless of travel restrictions.

Institutional & Organizational Benefits:

• Enhance institutional visibility through international representation.
• Explore collaboration opportunities with global research groups and industry partners.
• Identify new technologies, clinical tools, and research advancements for institutional growth.

Cultural & Experiential Value (Onsite Participants):

• Experience Paris—its culture, science, cuisine, and historic landmarks.
• Take part in networking dinners, social gatherings, and optional city tours.
• Combine scientific enrichment with a memorable international travel experience.

Certification & Recognition:

All participants receive:

• Certificate of Participation
• Certificate of Presentation (for presenters)
• Official endorsement from the 6th World Congress on Congestive Heart Failure & Angina

These recognitions support academic portfolios, job applications, and future grant proposals.

Abstract Review Process

Our abstract review process ensures academic rigor and fair evaluation:

Submission: Authors submit abstracts through the official online portal.

Pre-Screening: The editorial team verifies topic relevance, clarity, and structure.

Double-Blind Evaluation: Each abstract is reviewed by two independent experts specializing in gastroenterology and liver or related fields.

Scoring Criteria:

• Scientific merit and originality
• Practical implications for congestive heart failure and angina
• Methodological accuracy
• Relevance to conference themes

Decision & Notification: Accepted abstracts are assigned to Oral, Poster, or Virtual Presentation categories. Feedback and revision suggestions may be offered where applicable.

Early Acceptance Advantage: Early submissions are given priority in program scheduling, allowing authors to secure preferred presentation slots.

VISA Process

We support all international participants in successfully completing their visa application process. Once your registration is confirmed, the organizing committee will provide:

• A formal Invitation Letter
• Accommodation confirmation (if booked through the conference)
• A detailed conference schedule
• Proof of registration and payment

These documents assist in meeting the requirements of the French Embassy or Consulate in your region.

General Visa Requirements

Participants may be asked to provide:

• A valid passport
• Completed visa application form
• Invitation letter from the conference
• Proof of accommodation and travel itinerary
• Registration confirmation

We strongly recommend applying 6–8 weeks in advance to avoid last-minute complications.

In Case of Visa Rejection: Refund & Participation Options:

We understand that visa outcomes vary from country to country. Therefore, our policy is designed to support you:

If your visa is rejected, you may switch to Virtual Presentation or Virtual Participation without any deduction.

If you prefer to request a refund, the organizing committee will process it after receiving the official visa rejection letter from the embassy or consulate.

Refund requests must be submitted within 10 days of receiving the rejection notice.

Processing timelines for refunds are typically 2–3 weeks.

Registration can also be transferred to the next edition of the conference without additional fees if preferred.

This ensures that your research and contribution remain part of the scientific program—even if you cannot travel physically.

Market Analysis

The global cardiovascular market continues to grow rapidly, driven by the rising prevalence of heart failure, aging populations, and innovations in treatment and diagnostics.

The global heart failure therapeutics market is projected to surpass USD 20 billion by 2030, fueled by advances in drug therapies and device technologies.

The cardiac devices market (including pacemakers, defibrillators, and ventricular assist devices) is expected to grow steadily at a CAGR of over 6% through 2030.

Digital health and remote monitoring in cardiology are expanding significantly, offering opportunities for tele-cardiology, AI-driven diagnostics, and wearable devices.

Regenerative medicine and gene therapy are emerging as promising frontiers for advanced heart failure treatment.

Global initiatives for preventive cardiology and lifestyle-based interventions are increasing, with a focus on reducing healthcare costs and improving patient outcomes.

The congress provides a unique opportunity for stakeholders to align with market trends, foster partnerships, and accelerate progress in the global fight against heart failure and angina.